Inovio Pharmaceuticals | 8-K: Current report
Inovio Pharmaceuticals | 8-K: INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Inovio Pharmaceuticals | 8-K: Current report
Inovio Pharmaceuticals | 8-K: INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
Inovio Pharmaceuticals | 8-K: Current report
Inovio Pharmaceuticals | DEF 14A: Definitive information statements
Inovio Pharmaceuticals | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
Inovio Pharmaceuticals | 8-K: Current report
Inovio Pharmaceuticals | 8-K: Current report
Inovio Pharmaceuticals | DEF 14A: Definitive information statements
Inovio Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Inovio Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Inovio Pharmaceuticals | 8-K: INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights
Inovio Pharmaceuticals | 8-K: Current report
Inovio Pharmaceuticals | 8-K: Current report
Inovio Pharmaceuticals | 8-K: INOVIO Announces Second Quarter 2023 Financial Results and Provides Strategic Update
Inovio Pharmaceuticals | 8-K: Current report
Inovio Pharmaceuticals | 8-K: Current report
Inovio Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Inovio Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
No Data
No Data